Aqueous extract of Scrophularia ningpoensis improves insulin sensitivity through AMPK-mediated inhibition of the NLRP3 inflammasome.

Abstract

BACKGROUND:

Scrophularia ningpoensis Hemsl. is a commonly used medicinal plant in China for the treatment of diabetes mellitus (DM), but its mechanism of action remains poorly described. Type 2 diabetes mellitus (T2DM) accounts for > 90% of all DM cases and is characterized by insulin resistance.

PURPOSE:

The aim of this study was to investigate whether the insulin sensitivity can be improved by treatment with aqueous extract of S. ningpoensis (AESN) and further explore its mechanism(s) of activity.

METHODS:

Primary mouse hepatocytes and human HepG2 hepatocytes were used to investigate the effects of AESN on cell viability, AMP-activated protein kinase (AMPK) activation and glucose output under normal culture conditions. To mimic hyperglycemia and insulin resistance in vitro, hepatocytes were exposed to high glucose (HG), and the influences of AESN on AMPK phosphorylation, NLRP3 inflammation activation, insulin signaling, lipid accumulation and glucose output were investigated. Increasing doses of AESN (50, 100 and 200 mg/kg/day) were administered by gavage to db/db mice for 8 weeks, and then biochemical analysis and histopathological examinations were performed.

RESULTS:

AESN significantly activated AMPK and inhibited glucose output in hepatocytes, but did not impact cell viability under normal culture conditions. Moreover, in HG-treated hepatocytes, AESN protected against aberrant AMPK activity, NLRP3 inflammasome activation, insulin signaling, and lipid accumulation. AMPK inhibition abolished the regulatory effects of AESN on the NLRP3 inflammasome, insulin signaling, lipid accumulation, and glucose output of hepatocytes following HG exposure. Furthermore, AESN administration reduced blood glucose and serum insulin levels, improved lipid profiles and insulin resistance, and corrected the aberrant AMPK activity and NLRP3 inflammasome activation in liver tissues.

CONCLUSION:

AESN improves insulin sensitivity via AMPK-mediated NLRP3 inflammasome inhibition.

• Authors: Shan Yan, Wei Lu, Jun Zhou, Xu Guo, Juyi Li, Hongbo Cheng, Xiaoyan Zhu, Yan Zhao, Mingzhu Duan, Hongxu Yang, Yonghong Zhang, Qibin Wang, Li Chen, Tao Zheng
• Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology (Phytomedicine) Vol. 104 Pg. 154308 (Sep 2022) ISSN: 1618-095X [Electronic] Germany
• PMID: 35792447 (Publication Type: Journal Article)
• Copyright: Copyright © 2022. Published by Elsevier GmbH.

Chemical References

• Blood Glucose
• Inflammasomes
• Insulin
• Lipids
• NLR Family, Pyrin Domain-Containing 3 Protein
• Nlrp3 protein, mouse
• AMP-Activated Protein Kinases

Topics

• AMP-Activated Protein Kinases (metabolism)
• Animals
• Blood Glucose
• Diabetes Mellitus, Type 2 (drug therapy)
• Humans
• Inflammasomes (metabolism)
• Insulin (metabolism)
• Insulin Resistance
• Lipids
• Mice
• NLR Family, Pyrin Domain-Containing 3 Protein
• Scrophularia